• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[典型与非典型肺类癌——77例病例的病理及临床分析]

[Typical and atypical pulmonary carcinoids--pathologic and clinical analysis of 77 cases].

作者信息

Słodkowska J, Langfort R, Rudziński P, Kupis W

机构信息

Zakładu Patomorfologii, Instytutu Gruźlicy i Chorób Płuc w. Warszawie.

出版信息

Pneumonol Alergol Pol. 1998;66(5-6):297-303.

PMID:9857650
Abstract

Neuroendocrine tumors of the lung represent a group of controversial pulmonary neoplasms regarding their classification, criteria for diagnosis, predictors of future behavior, and therapy. The histologic criteria for their classification rest heavily on the proposed by Arrigoni et al. in 1972, for atypical carcinoid (AC). According to these authors AC has mitoses between 5 and 10 per 10 high power fields (HPF), necrosis, hypercellularity and disorganized architecture. The survival analysis performed by Flieder et al. (1997) for a variety of clinical and histologic features revised the histologic criteria for separating AC from typical carcinoid (TC) and proposed a range of mitotic counts between 2 and 20 per HPF for AC. From 1978 until 1997, 77 resected pulmonary carcinoids were reclassified for TCs and ACs according to Flieder's et al. histologic criteria. The clinical and pathological various features were studied for the group of 62 TCs and 15 ACs. 77 patients (pts) entered the study: 29(38%) males and 48(62%)females; mean age 43 years, range 18-75 years, 46 pts underwent lobectomies, 16 bilobectomies, 12 pneumonectomies and 3 wedge resections. The patients with TC were younger than those with AC (males: 40 vs 50 years and females 42 vs 49 years). TCs were significantly smaller than ACs (mean diameter respectively: 24 mm vs 33 mm). Fifty four (87%) of TCs and all ACs had central localization. The time of patients observation ranged from 2 months to 18 and half years; 2 patients with TC died due to tumours progression; 3 due to other diseases. Regional lymph node metastases occurred in 10% TCs and 33% ACs (p = 0.032). The heterotopic bone formation appeared in 11(18%) TCs and 2(13%) ACs. The mitotic counts for AC range between 2 and 6 per 10 HPF, accompanied by small foci of necrosis in 2 cases. Peripheral carcinoids showed a spindle-cell morphology. The performed study has highlighted the new concept of the carcinoids classification and the importance of the mitotic counts as histologic criteria for AC diagnosis. The data based on the largest in Polish literature lung carcinoids collection.

摘要

肺神经内分泌肿瘤在分类、诊断标准、未来行为预测指标及治疗方面是一组存在争议的肺部肿瘤。其分类的组织学标准很大程度上依据1972年阿里戈尼等人提出的非典型类癌(AC)标准。根据这些作者的观点,AC每10个高倍视野(HPF)中有5至10个核分裂象、坏死、细胞增多及结构紊乱。弗里德等人(1997年)针对多种临床和组织学特征进行的生存分析修订了区分AC与典型类癌(TC)的组织学标准,并提出AC每HPF的核分裂象计数范围为2至20个。从1978年至1997年,根据弗里德等人的组织学标准,对77例切除的肺类癌重新分类为TC和AC。对62例TC和15例AC患者的临床和病理特征进行了研究。77例患者纳入研究:男性29例(38%),女性48例(62%);平均年龄43岁,范围18至75岁,46例患者接受肺叶切除术,16例接受双肺叶切除术,12例接受全肺切除术,3例接受楔形切除术。TC患者比AC患者年轻(男性:40岁对50岁,女性:42岁对49岁)。TC明显小于AC(平均直径分别为:24毫米对33毫米)。54例(87%)TC和所有AC均位于中央。患者观察时间为2个月至18年半;2例TC患者因肿瘤进展死亡;3例因其他疾病死亡。10%的TC和33%的AC发生区域淋巴结转移(p = 0.032)。11例(18%)TC和2例(13%)AC出现异位骨形成。AC的核分裂象计数为每10个HPF 2至6个,2例伴有小灶性坏死。周围型类癌呈梭形细胞形态。本研究突出了类癌分类的新概念以及核分裂象计数作为AC诊断组织学标准的重要性。这些数据基于波兰文献中最大的肺类癌病例收集。

相似文献

1
[Typical and atypical pulmonary carcinoids--pathologic and clinical analysis of 77 cases].[典型与非典型肺类癌——77例病例的病理及临床分析]
Pneumonol Alergol Pol. 1998;66(5-6):297-303.
2
DNA topoisomerase II-alpha in pulmonary carcinoid tumors.
Pathol Res Pract. 2001;197(3):169-73. doi: 10.1078/0344-0338-00029.
3
Carcinoid tumors of the lung: do atypical features require aggressive management?肺类癌肿瘤:非典型特征是否需要积极治疗?
Ann Thorac Surg. 1995 Jan;59(1):78-83. doi: 10.1016/0003-4975(94)00630-P.
4
Pulmonary atypical carcinoid: predictors of survival in 106 cases.肺非典型类癌:106例患者的生存预测因素
Hum Pathol. 2000 Oct;31(10):1255-65. doi: 10.1053/hupa.2000.19294.
5
Interobserver variability for the WHO classification of pulmonary carcinoids.世界卫生组织肺类癌分类的观察者间变异性。
Am J Surg Pathol. 2014 Oct;38(10):1429-36. doi: 10.1097/PAS.0000000000000300.
6
[Heterogeneity of bronchial carcinoid tumors. Place of atypical forms].[支气管类癌肿瘤的异质性。非典型形态的地位]
Ann Chir. 1994;48(3):253-8.
7
Bronchial carcinoid tumors: nodal status and long-term survival after resection.支气管类癌肿瘤:切除术后的淋巴结状态及长期生存情况
Ann Thorac Surg. 2004 May;77(5):1781-5. doi: 10.1016/j.athoracsur.2003.10.089.
8
[Pulmonary carcinoid tumors].[肺类癌肿瘤]
Chir Ital. 1994;46(3):29-36.
9
Typical and atypical pulmonary carcinoids: our institutional experience.典型与非典型肺类癌:我们机构的经验
Interact Cardiovasc Thorac Surg. 2008 May;7(3):415-8. doi: 10.1510/icvts.2007.173328. Epub 2008 Mar 18.
10
[Expression of transforming growth factor beta 1 (TGF beta 1) and angiogenesis in broncho-pulmonary carcinoids].[转化生长因子β1(TGFβ1)的表达与支气管肺类癌中的血管生成]
Pneumonol Alergol Pol. 2000;68(7-8):319-26.

引用本文的文献

1
Partitioning of bronchopulmonary carcinoids in two different prognostic categories by ki-67 score.根据 Ki-67 评分将支气管肺类癌分为两个不同的预后类别。
Front Endocrinol (Lausanne). 2011 Aug 19;2:20. doi: 10.3389/fendo.2011.00020. eCollection 2011.